Nrx pharmaceuticals announces data sharing agreement demonstrating efficacy and safety of intravenous ketamine for the treatment of suicidal bipolar depression

Ketamine, an nmda blocker, was highly effective in bipolar subgroup (p

NRXP Ratings Summary

NRXP Quant Ranking